On January 10, 2014, the Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to alter key components of the Medicare Advantage and Part D Programs. The proposed rule would rescind an existing rule that prohibits the agency from releasing unencrypted prescriber, pharmacy and plan identifiers contained in prescription drug event records to certain external researchers. As CMS contemplates further expanding external researchers’ access to Part D data, stakeholders should be aware of how CMS will ultimately finalize these provisions in the forthcoming final rule.
Read the Special Report here.
